They are not equivalent in formulation, release profile, manufacturing control, clinical use or regulatory oversight
They are not rivals
Granhall C, Donsmark M, Blicher TM, Golor G, Sndergaard FL, Thomsen M, et al
By using the Website , User agrees that the Company will not be liable for any damages arising out of its website being unavailable at any time, for any reason
The GI side effects, while potentially improved with BPC-157 support, may still occur
For example, in the 2016 EPIC Study (which led to the conclusion that pimobendan should be used to treat MVD-affected dogs with enlarged hearts but not yet in CHF), its lead investigators made the totally unfounded assumption that all dogs (regardless of breed or size) with LA/Ao ratios less than 1.6 have normal sized LAs, and all dogs with LA/Ao ratios of 1.6 and above have enlarged LAs